Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
6.52
-0.17 (-2.54%)
Jul 6, 2026, 4:00 PM EDT - Market closed
Eupraxia Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $17 | Buy | Initiates | $17 | +160.74% | Jun 25, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $19 | Buy | Maintains | $19 | +191.41% | Jun 25, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Initiates $25 | Buy | Initiates | $25 | +283.44% | May 20, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $16 | Buy | Maintains | $16 | +145.40% | May 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $11 | Buy | Reiterates | $11 | +68.71% | May 14, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 14, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $14 | Buy | Reiterates | $14 | +114.72% | May 5, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $14 | Buy | Maintains | $14 | +114.72% | Apr 28, 2026 |